DISCLAIMER – IMPORTANT

This Offer to Purchase is important and requires your immediate attention. You should consult your investment dealer, stockbroker, bank manager, lawyer or other professional advisor. This Offer to Purchase has not been filed with or reviewed by any federal, state or foreign securities commission or regulatory authority, nor has any such commission or authority passed upon the accuracy or adequacy of this Offer to Purchase. Any representation to the contrary is unlawful and may be a criminal offense.

THIS OFFER TO PURCHASE CONTAINS CERTAIN IMPORTANT INFORMATION THAT SHOULD BE READ BEFORE ANY DECISION IS MADE WITH RESPECT TO THE TENDER OFFERS.

AuguStar Life Insurance Company (“AuguStar,” the “Offeror,” “us” or “we”), an Ohio corporation and a wholly owned subsidiary of Constellation Insurance, Inc. (“CII” or the “Issuer”), hereby offers, on the terms and subject to the conditions set forth in the Tender Offer Documents, to purchase for cash, subject to the Aggregate Tender Cap (as defined below) [and Yield Condition (as defined below) , the Notes set forth in the table on the cover page of this Offer to Purchase (the “Notes” and, each, a “Series” of Notes) issued by CII from each registered holder (each, a “Holder” and collectively, the “Holders”) of such Notes. The 5.550% Senior Notes due 2030 are referred to herein as the “2030 Notes,” and the 6.625% Senior Notes due 2031 are referred to herein as the “2031 Notes.” This Offer to Purchase relates to the two separate offers, one for each Series of Notes (each, a “Tender Offer” and, collectively, the “Tender Offers”). The Tender Offers are open to all registered Holders of the Notes, subject to an $80,000,000 cap on the combined aggregate principal amount of Notes of both Series that may be purchased in the Tender Offers (the “Aggregate Tender Cap”). Additionally, we may increase the amount of Notes of either Series accepted for purchase in the Tender Offers by no more than 2% of the aggregate principal amount of Notes outstanding of such Series, without amending or extending the Tender Offers, as further described in the Proration Procedures set forth below. If the aggregate principal amount of all Notes validly tendered exceeds the Aggregate Tender Cap, the Notes of both Series will be subject to proration on the same basis as described under “The Tender Offers—Proration Procedures.” Notwithstanding any other provision of this Offer to Purchase, if at the Price Determination Date (as defined below) the bid-side yield of the Reference Security specified on the cover page of this Offer to Purchase as quoted on the Bloomberg Reference Page is less than 4.75%, we will not be required to
(1) accept for purchase any validly tendered Notes of any Series or
(2) pay any cash amounts or complete the applicable Tender Offer, and may terminate or amend one or both Tender Offers (the “Yield Condition”).

The Tender Offers are subject to the Yield Condition but are not conditioned upon the tender of any aggregate minimum principal amount of Notes of either Series (subject to minimum denomination requirements as set forth in “The Tender Offers—Procedures for Tendering Notes—Minimum Tender Denomination”), and neither of the Tender Offers is conditioned on the consummation of the other Tender Offer. See “The Tender Offers—Conditions to the Tender Offers.”

This Offer to Purchase and related documents do not constitute an offer to buy or sell or the solicitation of an offer to buy or sell any Notes in any jurisdictions or in any circumstances in which such offer or solicitation is unlawful.

The Tender Offers are subject to the terms and conditions described in this Offer to Purchase. Subject to applicable law, we reserve the right to
(i) waive any and all conditions to any or all of the Tender Offers as permitted by law,
(ii) extend or terminate the Tender Offers, including the Expiration Date, or (iii) otherwise amend any of the Tender Offers.

The Tender Offers are, however, subject to the terms and conditions described in this Offer to Purchase, including, among others, the Proration Procedures, the Aggregate Tender Cap and the Yield Condition. Subject to applicable law, we may waive or increase the Aggregate Tender Cap and/or waive the Yield Condition at any time prior to the Expiration Date.

Subject to the satisfaction or waiver of the conditions of the Tender Offers described in this Offer to Purchase, if the aggregate principal amount of all Notes validly tendered by Holders at or prior to the Expiration Date does not exceed the Aggregate Tender Cap, then we will accept all such Notes. However, if the aggregate principal amount of all Notes validly tendered at or prior to the Expiration Date exceeds the Aggregate Tender Cap (subject to any increase in such Aggregate Tender Cap at our discretion), Notes of both Series will be accepted on an equal pro rata basis, without any acceptance priority between the Series, pursuant to the proration mechanics set forth under “The Tender Offers—Proration Procedures.” We may, without extending the Tender Offers or providing additional notice, increase the principal amount of Notes of either Series accepted for purchase by up to 2% of the outstanding principal amount of such Series. If proration is required, we will use commercially reasonable efforts to announce the proration factor applicable to both Series of Notes by press release by 10:00 a.m., New York City time, on the business day after the Expiration Date, or as soon thereafter as practicable.

In addition to the Tender Consideration, all Holders of Notes accepted for purchase pursuant to the Tender Offers will, on the Settlement Date (as defined below), also receive accrued and unpaid interest on those Notes from the last interest payment date with respect to those Notes to, but excluding, the Settlement Date (the “Accrued Interest,” and the payment thereof, the “Accrued Interest Payment”). See “The Tender Offers—Accrued Interest Payment.”

Provided that all conditions to the Tender Offers have been satisfied or waived by us by the Expiration Date, we will settle all Notes validly tendered at or prior to the Expiration Date and accepted for purchase in such Tender Offers on the second business day after the Expiration Date, which is expected to be November 27, 2026 unless extended with respect to any Tender Offer (the “Settlement Date”).

NONE OF THE OFFEROR, THE ISSUER, THE TENDER AND INFORMATION AGENT, THE DEALER MANAGER OR THE TRUSTEE (EACH AS DEFINED HEREIN) (NOR ANY OF THEIR RESPECTIVE DIRECTORS, OFFICERS, EMPLOYEES OR AFFILIATES) MAKES ANY RECOMMENDATION AS TO WHETHER HOLDERS SHOULD TENDER THEIR NOTES PURSUANT TO ANY TENDER OFFER, AND NO ONE HAS BEEN AUTHORIZED BY ANY OF THEM TO MAKE SUCH A RECOMMENDATION. HOLDERS MUST MAKE THEIR OWN DECISIONS AS TO WHETHER TO TENDER THEIR NOTES, AND, IF SO, THE PRINCIPAL AMOUNT OF NOTES TO TENDER.

Neither the Dealer Manager nor any of its respective directors, officers, employees or affiliates assumes any responsibility for the accuracy or completeness of the information contained in this Offer to Purchase or any related documents, including the information concerning the Tender Offers, the Offeror or the Issuer contained in this Offer to Purchase or for any failure by the Offeror or the Issuer to disclose events that may have occurred and may affect the significance or accuracy of such information.

Holders must also obtain any consents or approvals that they need in order to tender their Notes. None of the Offeror, the Dealer Manager, the Tender and Information Agent or the Trustee is responsible for Holders’ compliance with these requirements.

You should consider the risk factors described under “Risk Factors” of this Offer to Purchase before you decide whether to participate in the Tender Offers.

By clicking on the “I AGREE” button, I

I have read and agree to the Terms and Conditions